Board of Scientific Counselors, National Center for Injury Prevention and Control, 49463-49464 [2023-16104]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 145 / Monday, July 31, 2023 / Notices
to Debra A. Decker, Executive Secretary
of the Corporation, at 202–898–8748.
Dated this the 27th day of July, 2023.
Federal Deposit Insurance Corporation.
James P. Sheesley,
Assistant Executive Secretary.
[FR Doc. 2023–16306 Filed 7–27–23; 4:15 pm]
BILLING CODE 6714–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors,
National Center for Health Statistics
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with regulatory
provisions, the Centers for Disease
Control and Prevention (CDC)
announces the following meeting for the
Board of Scientific Counselors, National
Center for Health Statistics (BSC,
NCHS). This meeting is open to the
public. Time will be available for public
comment.
DATES: The meeting will be held on
September 14, 2023, from 11 a.m. to 5
p.m., EDT.
ADDRESSES: Instructions to access the
live meeting broadcast will be posted
here: https://www.cdc.gov/nchs/about/
bsc/bsc_meetings.htm.
FOR FURTHER INFORMATION CONTACT:
Rebecca Hines, M.H.S., Designated
Federal Officer, Board of Scientific
Counselors, National Center for Health
Statistics, Centers for Disease Control
and Prevention, 3311 Toledo Road,
Mailstop P–08, Hyattsville, Maryland
20782. Telephone: (301) 458–4715;
Email: RSHines@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Board of Scientific
Counselors, National Center for Health
Statistics (BSC, NCHS) is charged with
providing advice and making
recommendations to the Secretary,
Department of Health and Human
Services; the Director, Centers for
Disease Control and Prevention; and the
Director, National Center for Health
Statistics, regarding the scientific and
technical program goals and objectives,
strategies, and priorities of NCHS.
Matters to Be Considered: The
meeting agenda will include an update
from the NCHS Director; an update on
the role of artificial intelligence and
machine learning in NCHS programs; an
update from NCHS on long-term health
ddrumheller on DSK120RN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
18:11 Jul 28, 2023
Jkt 259001
care data collection; an update from
NCHS on the National Health Interview
Survey; and discussion regarding
current issues and topics. The Board
will reserve time for public comment at
the end of the day. Meeting times and
agenda topics are subject to change as
priorities dictate.
Meeting Information: Please visit the
BSC, NCHS website for details: https://
www.cdc.gov/nchs/about/bsc/bsc_
meetings.htm. Further information and
the meeting agenda will be available on
the website, including any agenda
updates and the instructions for
accessing the live meeting broadcast.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2023–16103 Filed 7–28–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors,
National Center for Injury Prevention
and Control
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of closed meeting.
AGENCY:
In accordance with regulatory
provisions, the Centers for Disease
Control and Prevention (CDC)
announces the following meeting for the
Board of Scientific Counselors, National
Center for Injury Prevention and Control
(BSC, NCIPC or Board). This meeting is
partially open to the public.
DATES: The meeting will be held on
September 20, 2023. The first session of
the day will be held from 1 p.m. to 2:30
p.m., EDT (OPEN), and the second
session will be held from 2:30 p.m. to
4:30 p.m., EDT (CLOSED). The public
comment period will be at the end of
the open session of the meeting, from
2:10 p.m. to 2:25 p.m., EDT.
ADDRESSES: Webinar, Atlanta, Georgia.
All participants must register by using
SUMMARY:
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
49463
the following link to attend the open
session: https://cdc.zoomgov.com/
webinar/register/WN_
6fMCRBe2SzmPnasMtiyF_Q.
FOR FURTHER INFORMATION CONTACT:
Christopher R. Harper, Ph.D.,
Designated Federal Officer, Board of
Scientific Counselors, National Center
for Injury Prevention and Control,
Centers for Disease Control and
Prevention, 4770 Buford Highway, NE,
Mailstop S–1069, Atlanta, Georgia
30341. Telephone: (404) 718–8330;
Email: ncipcbsc@cdc.gov.
SUPPLEMENTARY INFORMATION: Portions
of the meeting referenced above will be
closed to the public in accordance with
provisions set forth in section 552b(c)(4)
and (6), title 5, U.S.C., and the
Determination of the Director, Strategic
Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for
Disease Control and Prevention,
pursuant to 5 U.S.C. 1009 (Pub. L. 92–
463, as amended).
Purpose: The Board of Scientific
Counselors, National Center for Injury
Prevention and Control (BSC, NCIPC or
Board) will: (1) conduct, encourage,
cooperate with, and assist other
appropriate public health authorities,
scientific institutions, and scientists in
the conduct of research, investigations,
experiments, demonstrations, and
studies relating to the causes and
strategies related to the prevention of
injury and violence; (2) assist States and
other entities in preventing intentional
and unintentional injuries, and to
promote health and well-being; and (3)
make recommendations of grants and
cooperative agreements for research and
prevention activities related to injury
and violence. The BSC, NCIPC makes
recommendations regarding policies,
strategies, objectives, and priorities and
reviews progress toward injury and
violence prevention. The Board also
provides advice on the appropriate
balance of intramural and extramural
research and provides guidance on the
needs, structure, progress, and
performance of intramural programs.
Further, the Board provides guidance on
extramural scientific program matters.
Additionally, the Board provides
second-level scientific and
programmatic review of applications for
research grants, cooperative agreements,
and training grants related to injury and
violence prevention, and recommends
approval of projects that merit further
consideration for funding support.
Finally, the Board also recommends
areas of research to be supported by
contracts and cooperative agreements
and provides concept reviews of
program proposals and announcements.
E:\FR\FM\31JYN1.SGM
31JYN1
49464
Federal Register / Vol. 88, No. 145 / Monday, July 31, 2023 / Notices
Matters to be Considered: The open
session of the meeting will include a
discussion on the updated Intimate
Partner Violence Prevention Research
Priorities. The closed session of the
meeting will focus on the Secondary
Peer Review of extramural research
grant applications received in response
to one (1) Notice of Funding
Opportunity: RFA–CE–24–001—‘‘Grants
for Injury Control Research Centers.’’
Agenda items are subject to change as
priorities dictate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2023–16104 Filed 7–28–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Solicitation of Nominations for
Appointment to CDC’s Advisory
Committee to the Director Data and
Surveillance Workgroup
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), within
the Department of Health and Human
Services (HHS), is seeking nominations
for membership on the Advisory
Committee to the Director Data and
Surveillance Workgroup (DSW). The
DSW consists of approximately 15
members who are experts in fields
associated with public health science
and practice; policy development,
analysis, and implementation; and
surveillance and informatics.
DATES: Nominations for membership on
the DSW must be received no later than
August 30, 2023. Late nominations will
not be considered for membership.
ADDRESSES: All nominations (cover
letters and curriculum vitae) should be
emailed to DSWACD@cdc.gov with the
ddrumheller on DSK120RN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
18:11 Jul 28, 2023
Jkt 259001
subject line: ‘‘Nomination for CDC ACD
DSW Workgroup.’’
FOR FURTHER INFORMATION CONTACT:
Agnes Warner, MPA, Office of Public
Health Data, Surveillance, and
Technology, Centers for Disease Control
and Prevention, 1600 Clifton Road NE,
Mailstop H21–10, Atlanta, Georgia
30329–4027. Telephone: (404) 639–
3372; Email: DSWACD@cdc.gov.
SUPPLEMENTARY INFORMATION:
Background: The purpose of the
Advisory Committee to the Director,
Centers for Disease Control and
Prevention (ACD, CDC) is to (1) make
recommendations to the Director
regarding ways to prioritize the
activities of the agency in alignment
with the CDC Strategic Plan required
under section 305(c); H.R. 2617–1252;
(2) advise on ways to achieve or
improve performance metrics in relation
to the CDC Strategic Plan, and other
relevant metrics, as appropriate; (3)
provide advice and recommendations
on the development of the Strategic
Plan, and any subsequent updates, as
appropriate; (4) advise on grants,
cooperative agreements, contracts, or
other transactions, as applicable; (5)
provide other advice to the Director, as
requested, to fulfill duties under
sections 301 and 311; and (6) appoint
subcommittees. The ACD, CDC consists
of up to 15 non-federal members,
including the Chair, knowledgeable in
areas pertinent to the CDC mission, such
as health policy, public health, global
health, preparedness, preventive
medicine, the faith-based and
community-based sector, and allied
fields.
Purpose: The purpose of the ACD,
CDC Data and Surveillance Workgroup
(DSW) is to provide input to the
Committee on agency-wide activities
related to the scope and implementation
of CDC’s data modernization strategy
across the agency, ultimately playing a
key role in the agency’s work with
public health, healthcare, and academic
and private sector partners and with the
promotion of equity. The DSW
membership consists of approximately
15 members. It is co-chaired by two
current ACD, CDC Special Government
Employees. The DSW co-chairs will
present their findings, observations, and
work products at one or more ACD, CDC
meetings for discussion, deliberation,
and decisions (final recommendations
to CDC).
Nomination Criteria: DSW members
will serve terms ranging from six
months to one year and be required to
attend DSW meetings approximately 1–
2 times per month (virtually or in
person), and contribute time in between
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
meetings for research, consultation,
discussion, and writing assignments.
Nominations are being sought for
individuals who have the expertise and
qualifications necessary to contribute to
the accomplishments of the
committee’s/workgroup’s objectives.
Nominees will be selected based on
expertise in the fields of public health
science and practice; public health
preparedness and response; public
health policy development, analysis,
and implementation; public health
surveillance and informatics; artificial
intelligence; data analysis, data science,
and forecasting; health information
technology; and healthcare delivery
from jurisdictional government
agencies, non-government
organizations, academia, and the private
sector. To ensure a diverse workgroup
composition, nominees with front line
and field experience at the local, state,
tribal, and territorial levels are
encouraged to apply. This includes
nominees with experience working for,
and with, community-based
organizations and other non-profit
organizations. Federal employees will
not be considered for membership.
Selection of members is based on
candidates’ qualifications to contribute
to the accomplishment of the DSW’s
objectives.
HHS policy stipulates that
membership be balanced in terms of
points of view represented and the
workgroup’s function. Appointments
shall be made without discrimination
based on age, race, ethnicity, gender,
sexual orientation, gender identity, HIV
status, disability, and cultural, religious,
or socioeconomic status. Nominees
must be U.S. citizens. Current
participation on federal workgroups or
prior experience serving on a federal
advisory committee does not disqualify
a candidate; however, HHS policy is to
avoid excessive individual service on
advisory committees and multiple
committee memberships. Interested
candidates should submit the following
items:
D A one-half to one-page cover letter
that includes your understanding of,
and commitment to, the time and work
necessary; one to two sentences on your
background and experience; and one to
two sentences on the skills/perspective
you would bring to the DSW.
D Current curriculum vitae which
highlights the experience and work
history being sought relevant to the
criteria set forth above, including
complete contact information
(telephone numbers, mailing address,
email address).
E:\FR\FM\31JYN1.SGM
31JYN1
]]>Agencies
[Federal Register Volume 88, Number 145 (Monday, July 31, 2023)]
[Notices]
[Pages 49463-49464]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-16104]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, National Center for Injury
Prevention and Control
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of closed meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with regulatory provisions, the Centers for
Disease Control and Prevention (CDC) announces the following meeting
for the Board of Scientific Counselors, National Center for Injury
Prevention and Control (BSC, NCIPC or Board). This meeting is partially
open to the public.
DATES: The meeting will be held on September 20, 2023. The first
session of the day will be held from 1 p.m. to 2:30 p.m., EDT (OPEN),
and the second session will be held from 2:30 p.m. to 4:30 p.m., EDT
(CLOSED). The public comment period will be at the end of the open
session of the meeting, from 2:10 p.m. to 2:25 p.m., EDT.
ADDRESSES: Webinar, Atlanta, Georgia. All participants must register by
using the following link to attend the open session: https://cdc.zoomgov.com/webinar/register/WN_6fMCRBe2SzmPnasMtiyF_Q.
FOR FURTHER INFORMATION CONTACT: Christopher R. Harper, Ph.D.,
Designated Federal Officer, Board of Scientific Counselors, National
Center for Injury Prevention and Control, Centers for Disease Control
and Prevention, 4770 Buford Highway, NE, Mailstop S-1069, Atlanta,
Georgia 30341. Telephone: (404) 718-8330; Email: [email protected].
SUPPLEMENTARY INFORMATION: Portions of the meeting referenced above
will be closed to the public in accordance with provisions set forth in
section 552b(c)(4) and (6), title 5, U.S.C., and the Determination of
the Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention, pursuant
to 5 U.S.C. 1009 (Pub. L. 92-463, as amended).
Purpose: The Board of Scientific Counselors, National Center for
Injury Prevention and Control (BSC, NCIPC or Board) will: (1) conduct,
encourage, cooperate with, and assist other appropriate public health
authorities, scientific institutions, and scientists in the conduct of
research, investigations, experiments, demonstrations, and studies
relating to the causes and strategies related to the prevention of
injury and violence; (2) assist States and other entities in preventing
intentional and unintentional injuries, and to promote health and well-
being; and (3) make recommendations of grants and cooperative
agreements for research and prevention activities related to injury and
violence. The BSC, NCIPC makes recommendations regarding policies,
strategies, objectives, and priorities and reviews progress toward
injury and violence prevention. The Board also provides advice on the
appropriate balance of intramural and extramural research and provides
guidance on the needs, structure, progress, and performance of
intramural programs. Further, the Board provides guidance on extramural
scientific program matters. Additionally, the Board provides second-
level scientific and programmatic review of applications for research
grants, cooperative agreements, and training grants related to injury
and violence prevention, and recommends approval of projects that merit
further consideration for funding support. Finally, the Board also
recommends areas of research to be supported by contracts and
cooperative agreements and provides concept reviews of program
proposals and announcements.
[[Page 49464]]
Matters to be Considered: The open session of the meeting will
include a discussion on the updated Intimate Partner Violence
Prevention Research Priorities. The closed session of the meeting will
focus on the Secondary Peer Review of extramural research grant
applications received in response to one (1) Notice of Funding
Opportunity: RFA-CE-24-001--``Grants for Injury Control Research
Centers.'' Agenda items are subject to change as priorities dictate.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-16104 Filed 7-28-23; 8:45 am]
BILLING CODE 4163-18-P
